In this study, our results provide initial evidence of the anticancer effect of auranofin on human ovarian cancer cells, in which auranofin treatment downregulates the expression of IKK-β and reduces the level of phospho-IκBα (p-IκBα) (Fig. 6). The gene discussed is NFKBIA; the disease is ovarian carcinoma.